W
Wojciech Larczyński
Researcher at Gdańsk Medical University
Publications - 12
Citations - 233
Wojciech Larczyński is an academic researcher from Gdańsk Medical University. The author has contributed to research in topics: Kidney disease & Angiotensin-converting enzyme. The author has an hindex of 7, co-authored 12 publications receiving 223 citations.
Papers
More filters
Journal ArticleDOI
Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.
Leszek Tylicki,Przemysław Rutkowski,Marcin Renke,Wojciech Larczyński,Ewa Aleksandrowicz,Wieslawa Lysiak-Szydlowska,Bolesław Rutkowski +6 more
TL;DR: Administration of an aldosterone receptor antagonist in addition to double RAAS blockade with an ACE inhibitor and ARB may slow the progression of chronic kidney disease.
Journal ArticleDOI
Renal protective effects of the renin-angiotensin-aldosterone system blockade: from evidence-based approach to perspectives
TL;DR: An evidence-based approach on the use of RAAS-inhibiting agents in kidney diseases is reviewed, treatment strategies in different clinical situations are considered and some perspectives related to the implementation of the RAAS blockade in renal protection are discussed.
Journal ArticleDOI
The Effect of N-Acetylcysteine on Proteinuria and Markers of Tubular Injury in Non-Diabetic Patients with Chronic Kidney Disease
Marcin Renke,Leszek Tylicki,Przemysław Rutkowski,Wojciech Larczyński,Ewa Aleksandrowicz,Wiesława Łysiak-Szydłowska,Bolesław Rutkowski +6 more
TL;DR: NAC had no effect on proteinuria, surrogate markers of tubular injury or renal fibrosis in non-diabetic patients with chronic kidney disease.
Journal Article
The effect of N-acetylcysteine on blood pressure and markers of cardiovascular risk in non-diabetic patients with chronic kidney disease: a placebo-controlled, randomized, cross-over study.
Marcin Renke,Leszek Tylicki,Przemysław Rutkowski,Wojciech Larczyński,Alexander Neuwelt,Ewa Aleksandrowicz,Wieslawa Lysiak-Szydlowska,Bolesław Rutkowski +7 more
TL;DR: NAC had no effect on blood pressure and surrogate markers of cardiovascular injury in non-diabetic patients with CKD, as evaluated in a placebo-controlled, randomized, two-period cross-over study.
Journal ArticleDOI
Spironolactone Attenuates Oxidative Stress in Patients With Chronic Kidney Disease
Marcin Renke,Leszek Tylicki,Narcyz Knap,Przemysław Rutkowski,Alexander Neuwelt,Wojciech Larczyński,Michal Wozniak,Bolesław Rutkowski +7 more
TL;DR: The results of a recent clinical study indicate that spironolactone acts to decrease the amount of oxidative stress in patients being treated for chronic kidney disease.